Adaptive designs in clinical trials

In addition to the expensive and lengthy process of developing a new medicine, the attrition rate in clinical research was on the rise, resulting in stagnation in the development of new compounds. As a consequence to this, the US Food and Drug Administration released a critical path initiative docum...

Full description

Bibliographic Details
Main Author: Suresh Bowalekar
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2011-01-01
Series:Perspectives in Clinical Research
Subjects:
Online Access:http://www.picronline.org/article.asp?issn=2229-3485;year=2011;volume=2;issue=1;spage=23;epage=27;aulast=Bowalekar